Goldstein D J, Weller S K
Department of Microbiology, University of Connecticut Health Center, Farmington 06032-9984.
J Virol. 1988 Aug;62(8):2970-7. doi: 10.1128/JVI.62.8.2970-2977.1988.
An insertional mutagen was developed which consists of the lacZ gene of Escherichia coli under the control of the regulatory elements of the large subunit of ribonucleotide reductase (ICP6). This ICP6::lacZ cassette was used to create a mutation in a gene designated UL52 (D. J. McGeoch, M. A. Dalrymple, A. Dolan, D. McNab, L. J. Perry, P. Taylor, and M. D. Challberg, J. Virol. 62:444-453, 1988), which is predicted to encode a 114,000-molecular-weight protein. To isolate and propagate this mutant, we generated a cell line, BL-1, by cotransfection of Vero cells with pSV2neo and a plasmid containing the herpes simplex virus type 1 KOS strain BamHI L fragment (coordinates 0.708 to 0.745). An ICP6::lacZ insertion mutant, hr114, was capable of growing in BL-1 cells but not in normal Vero cells. In addition, hr114 was defective in the synthesis of viral DNA and late proteins; however, this mutant appeared to exhibit normal early gene expression. Thus, the results presented in this report show that the UL52 gene product is required for viral DNA synthesis. Furthermore, our studies indicate that the ICP6::lacZ cassette will provide a useful tool for obtaining mutants of other herpes simplex virus genes.
构建了一种插入诱变剂,其由大肠杆菌的lacZ基因组成,该基因受核糖核苷酸还原酶大亚基(ICP6)的调控元件控制。这个ICP6::lacZ盒式结构用于在一个名为UL52的基因中产生突变(D. J. 麦吉奥克、M. A. 达尔林普尔、A. 多兰、D. 麦克纳布、L. J. 佩里、P. 泰勒和M. D. 查尔伯格,《病毒学杂志》62:444 - 453, 1988),预计该基因编码一种分子量为114,000的蛋白质。为了分离和繁殖这种突变体,我们通过用pSV2neo和一个含有单纯疱疹病毒1型KOS株BamHI L片段(坐标0.708至0.745)的质粒共转染Vero细胞,产生了一个细胞系BL - 1。一个ICP6::lacZ插入突变体hr114能够在BL - 1细胞中生长,但不能在正常Vero细胞中生长。此外,hr114在病毒DNA和晚期蛋白的合成方面存在缺陷;然而,该突变体似乎表现出正常的早期基因表达。因此,本报告中的结果表明,UL52基因产物是病毒DNA合成所必需的。此外,我们的研究表明,ICP6::lacZ盒式结构将为获得其他单纯疱疹病毒基因的突变体提供一个有用的工具。